Form 4: USANA Health Sciences Director Gilbert A. Fuller Reports Stock Transaction
SEC Form 4 Filing
Director Gilbert A. Fuller reports a transaction involving USANA Health Sciences Inc. stock, including the vesting of restricted stock units.
Summary
- On August 2, 2024, Gilbert A. Fuller, a director of USANA Health Sciences Inc., reported a transaction involving the company's stock.
- The transaction involved the vesting of 674 restricted stock units, which converted into 674 shares of common stock.
- Following the transaction, Fuller directly owns 2,023 derivative securities.
- The restricted stock units vest in four equal installments: August 2, 2024, November 2, 2024, February 2, 2025, and May 2, 2025.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, so the sentiment is neutral.
Industry Context
This is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency into the holdings and transactions of company insiders.
Stakeholder Impact
- The transaction has a minor impact on shareholders as it reflects an insider's compensation and ownership stake.
Key Dates
| Date | Description |
|---|---|
| 08/02/2024 | Date of transaction: vesting of restricted stock units and conversion to common stock. |
| 08/02/2024 | 25% of restricted stock units vest. |
| 11/02/2024 | 25% of restricted stock units vest. |
| 02/02/2025 | 25% of restricted stock units vest. |
| 05/02/2025 | 25% of restricted stock units vest. |
| 08/05/2024 | Date of signature by Attorney-in-Fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.